Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Oct;28(5):303-8.
doi: 10.1111/j.1365-2257.2006.00812.x.

Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states

Affiliations

Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states

C Brugnara et al. Clin Lab Haematol. 2006 Oct.

Abstract

Direct measurement of the reticulocyte hemoglobin content provides useful information for the diagnosis and treatment of iron-deficient states. We have examined direct measurements of reticulocyte and red cell hemoglobin content on the Sysmex XE 2100 (Ret He and RBC He respectively) and the Bayer ADVIA 2120 (CHr and CH respectively) analyzers. Good agreement was found between Ret He and CHr (Y = 1.04X - 1.06; r2= 0.88) and between the RBC He and CH parameters (Y = 0.93X + 1; r2= 0.84 n = 200) in pediatric patients and in normal adults (Ret He and CHr; Y = 1.06X - 0.43; r2= 0.83; n = 126; RBC He and CH; Y = 0.94X + 1; r2= 0.87; n = 126). In 1500 blood samples from patients on chronic dialysis, Ret He was compared with traditional parameters for iron deficiency (serum iron <40 microg/dl, Tsat <20%, ferritin <100 ng/ml, hemoglobin <11 g/dl) for identifying iron-deficient states. Receiver operator characteristic (ROC) curve analysis revealed values of the area under the curve for Ret He of 0.913 (P < 0.0001). With a Ret He cutoff level of 27.2 pg, iron deficiency could be diagnosed with a sensitivity of 93.3%, and a specificity of 83.2%. Ret He is a reliable marker of cellular hemoglobin content and can be used to identify the presence of iron-deficient states.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Method comparison data, XE 2100 and ADVIA 2120: top, Ret He vs. CHr; bottom RBC He vs. CH. Data were obtained from 200 clinical samples and show good correlation between the Ret He and ADVIA CHr (Y = 1.04X − 1.06; r2 = 0.88) and between the RBC He and ADVIA CH (Y = 0.93X + 1; r2 = 0.84).
Figure 2
Figure 2
Method comparison data, XE 2100 and ADVIA 2120: top, Ret He vs. CHr; bottom RBC He vs. CH. Data were obtained from 126 normal adults, and show good correlation between the Ret He and ADVIA CHr (Y = 1.06 − 0.43; r2 = 0.83; n = 126) and between the RBC He and ADVIA CH (Y = 0.94X + 1; r2 = 0.87; n = 126).
Figure 3
Figure 3
In the top panel, the difference between Ret He and CHr is plotted vs. the mean value for the two parameters. In the bottom panel, the difference between RBC He and CH is plotted vs. the mean value for the two parameters. Data were combined for the 200 clinical samples and the 126 normal controls.
Figure 4
Figure 4
Top: ROC curve analysis for Ret He and the diagnosis of iron-deficiency anemia in hemodialysis patients. The diagnostic performance of Ret He in identifying iron-deficient states was compared with that of traditional parameters for iron deficiency (serum iron <40 μg/dl, Tsat <20%, ferritin <100 ng/ml, hemoglobin <11 g/dl). By using a Ret He cutoff level of 27.2 pg, iron deficiency could be diagnosed with a sensitivity of 93.3%, and a specificity of 83.2%. The area under the curve was 0.913. Bottom: ROC curve analysis for Ret He and the diagnosis of functional iron deficiency in hemodialysis patients. Functional iron deficiency was defined tests as Tsat <20%, Ferritin 100–800 ng/ml, and HGB <11 g/dl. The diagnostic performance of ret He is less favorable (area under the curve 0.657).

Similar articles

Cited by

References

    1. Brugnara C. Reticulocyte cellular indices: a new approach in the diagnosis of anemias and monitoring of erythropoietic function. Critical Reviews in Clinical Laboratory Sciences. 2000;37:93–130. - PubMed
    1. Brugnara C. Iron deficiency and erythropoiesis: New diagnostic approaches. Clinical Chemistry. 2003;49:1573–1578. - PubMed
    1. Brugnara C, Laufer MR, Friedman AI, Platt O. Reticulocyte hemoglobin content (Chr) – early indicator of response to iron therapy. Blood. 1993;82:A93. - PubMed
    1. Brugnara C, Colella GM, Cremins J, Langley RC, Schneider TJ, Rutherford CJ, Goldberg MA. Effects of subcutaneous recombinant-human-erythropoietin in normal subjects – development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis. Journal of Laboratory and Clinical Medicine. 1994a;123:660–667. - PubMed
    1. Brugnara C, Colella GM, Cremins JC, Langley RC, Schneider TJ, Rutheford CJ, Goldberg MA. Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis. The Journal of Laboratory and Clinical Medicine. 1994b;123:660–667. - PubMed

Publication types